ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.759,51
-0,01%
S&P 500
5.360,79
0,26%
US Dollar vs BRL
5,355
0,01%
Bitcoin
67.788,09
-2,48%
Brent Oil
81,445
-0,40%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Histogenics Corporation (HSGX)

  7. Histogenics Corporation (HSGX) Notícias

HSGX

Histogenics (HSGX)

Histogenics Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HSGX
DataHoraFonteTítuloCódigoCompanhia
21/11/201909:00GlobeNewswire Inc.Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial OfficerNASDAQ:HSGXHistogenics Corporation
12/11/201918:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HSGXHistogenics Corporation
08/11/201918:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HSGXHistogenics Corporation
08/11/201909:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HSGXHistogenics Corporation
06/11/201910:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:HSGXHistogenics Corporation
06/11/201908:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:HSGXHistogenics Corporation
28/10/201917:59Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:HSGXHistogenics Corporation
15/10/201916:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HSGXHistogenics Corporation
07/10/201918:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HSGXHistogenics Corporation
07/10/201918:29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:HSGXHistogenics Corporation
07/10/201914:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HSGXHistogenics Corporation
04/10/201913:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HSGXHistogenics Corporation
02/10/201909:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HSGXHistogenics Corporation
26/09/201918:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:HSGXHistogenics Corporation
26/09/201917:25GlobeNewswire Inc.Histogenics Corporation Announces Approval of Merger by Stockholders at Special MeetingNASDAQ:HSGXHistogenics Corporation
12/09/201910:15GlobeNewswire Inc.Histogenics Corporation Announces Adjournment of its Special Meeting to Thursday, September 26, 2019NASDAQ:HSGXHistogenics Corporation
11/09/201917:05GlobeNewswire Inc.Histogenics Corporation Announces Intent to Convene and Adjourn Its Special MeetingNASDAQ:HSGXHistogenics Corporation
02/08/201914:13Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:HSGXHistogenics Corporation
27/06/201917:32Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:HSGXHistogenics Corporation
14/06/201918:24Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:HSGXHistogenics Corporation
08/04/201908:00GlobeNewswire Inc.Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel...NASDAQ:HSGXHistogenics Corporation
22/03/201907:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HSGXHistogenics Corporation
14/02/201920:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HSGXHistogenics Corporation
12/02/201911:00GlobeNewswire Inc.Jonathan Lieber Joins Danforth Advisors as Managing DirectorNASDAQ:HSGXHistogenics Corporation
21/12/201819:05GlobeNewswire Inc.Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory PathwayNASDAQ:HSGXHistogenics Corporation
29/11/201811:30GlobeNewswire Inc.Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory PathwayNASDAQ:HSGXHistogenics Corporation
08/11/201809:30GlobeNewswire Inc.Histogenics Corporation Announces Third Quarter 2018 Financial and Operating ResultsNASDAQ:HSGXHistogenics Corporation
01/11/201817:05GlobeNewswire Inc.Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory PathwayNASDAQ:HSGXHistogenics Corporation
25/10/201817:15GlobeNewswire Inc.Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018NASDAQ:HSGXHistogenics Corporation
18/10/201817:48Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HSGXHistogenics Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:HSGX

Seu Histórico Recente

BIT
P1XNV2
NLBNPIT1XNV2 20351221 19...
BIT
P1X906
NLBNPIT1X906 20240621 29...
BIT
I09247
Intesa Sanpaolo
BIT
P1JPG7
BNP Paribas Issuance
LATK
STARXBTC
STARX
ASX
SHN
Sunshine Metals
LSE
0REO
The Swatch
NASDAQ
AAYQCXX
Bank of Montreal Capped ...
BIT
P1K1Z4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados